Subscribe Us

header ads

Recents

header ads

Ammunition Market Size At Around US$ 45.2 Bn In 2030

The ammunition market would grow at a CAGR of 3.95% over the predicted time frame. The market is expected to increase in value from US$ 33.16 Bn in 2022 to US$ 45.2 Bn in 2030.

Ammunition Market Size 2022 To 2030

The on ammunition Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2147

Report Scope of the Ammunition Market

Report Coverage Details
Market Size in 2022

USD 33.16 Billion

Market Size by 2030

USD 45.2 Billion

Growth Rate from 2022 to 2030 CAGR of 3.95%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Caliber, Product, End User, Component, Type, Guidance, Lethality, End-Use, Others and Geography

A recent report provides crucial insights along with application based and forecast information in the Global Ammunition Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Ammunition market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Ammunition market are included as given below:

Ammunition Market Key Players

  • Northrop Grumman Corporation
  • FN Herstal
  • Olin Corporation
  • General Dynamics Corporation
  • BAE Systems, Inc.
  • Rheinmetall Defense
  • Nexter KNDS Group
  • Hanwha Corporation
  • ST Engineering
  • Remington Arms Company LLC
  • Vista Outdoor Operations LLC

Market Segments

By Caliber

  • Small
  • Medium
  • Large
  • Artillery
  • Mortar

By Product

  • Rimfire
  • Centrefire

By End User

  • Civil & Commercial
    • Sports
    • Hunting
    • Self Defense
  • Defense
    • Military
    • Law Enforcement

By Component

  • Fuses & Primers
  • Gun Powder
  • Projectile
  • Cases
  • Others

By Type  

  • Bullets
  • Aerial Bombs
  • Grenades
  • Mortars
  • Artillery Shells
  • Others

By Guidance

  • Guided
  • Non-guided

By Lethality

  • Lethal
  • Less-lethal

By End-Use

  • Military & Homeland Security
  • Civil & Commercial
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Report Objectives

  • To define, describe, and forecast the global ammunition market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the ammunition market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Ammunition Market, By Caliber

7.1. Ammunition Market, by Caliber, 2022-2030

7.1.1. Small

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Medium

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Large

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Artillery

7.1.4.1. Market Revenue and Forecast (2017-2030)

7.1.5. Mortar

7.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Ammunition Market, By Product

8.1. Ammunition Market, by Product, 2022-2030

8.1.1. Rimfire

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Centrefire

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Ammunition Market, By End User

9.1. Ammunition Market, by End User, 2022-2030

9.1.1. Civil & Commercial

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Defense

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Ammunition Market, By Component

10.1. Ammunition Market, by Component, 2022-2030

10.1.1. Fuses & Primers

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Gun Powder

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Projectile

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Cases

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Ammunition Market, By Type

11.1. Ammunition Market, by Type, 2022-2030

11.1.1. Bullets

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Aerial Bombs

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Grenades

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Mortars

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Artillery Shells

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Ammunition Market, By Guidance

12.1. Ammunition Market, by Guidance, 2022-2030

12.1.1. Guided

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Non-guided

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Ammunition Market, By Lethality

13.1. Ammunition Market, by Lethality, 2022-2030

13.1.1. Lethal

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Less-lethal

13.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Ammunition Market, By End-Use

14.1. Ammunition Market, by End-Use, 2022-2030

14.1.1. Military & Homeland Security

14.1.1.1. Market Revenue and Forecast (2017-2030)

14.1.2. Civil & Commercial

14.1.2.1. Market Revenue and Forecast (2017-2030)

14.1.3. Others

14.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 15. Global Ammunition Market, Regional Estimates and Trend Forecast

15.1. North America

15.1.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.1.2. Market Revenue and Forecast, by Product (2017-2030)

15.1.3. Market Revenue and Forecast, by End User (2017-2030)

15.1.4. Market Revenue and Forecast, by Component (2017-2030)

15.1.5. Market Revenue and Forecast, by Type (2017-2030)

15.1.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.1.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.1.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.1.9. U.S.

15.1.9.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.1.9.2. Market Revenue and Forecast, by Product (2017-2030)

15.1.9.3. Market Revenue and Forecast, by End User (2017-2030)

15.1.9.4. Market Revenue and Forecast, by Component (2017-2030)

15.1.9.5.  Market Revenue and Forecast, by Type (2017-2030)

15.1.9.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.1.9.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.1.9.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.1.10. Rest of North America

15.1.10.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.1.10.2. Market Revenue and Forecast, by Product (2017-2030)

15.1.10.3. Market Revenue and Forecast, by End User (2017-2030)

15.1.10.4. Market Revenue and Forecast, by Component (2017-2030)

15.1.10.5. Market Revenue and Forecast, by Type (2017-2030)

15.1.10.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.1.10.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.1.10.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.2. Europe

15.2.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.2.2. Market Revenue and Forecast, by Product (2017-2030)

15.2.3. Market Revenue and Forecast, by End User (2017-2030)

15.2.4. Market Revenue and Forecast, by Component (2017-2030)

15.2.5. Market Revenue and Forecast, by Type (2017-2030)

15.2.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.2.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.2.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.2.9. UK

15.2.9.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

15.2.9.3. Market Revenue and Forecast, by End User (2017-2030)

15.2.9.4. Market Revenue and Forecast, by Component (2017-2030)

15.2.9.5. Market Revenue and Forecast, by Type (2017-2030)

15.2.9.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.2.9.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.2.9.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.2.10. Germany

15.2.10.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.2.10.2. Market Revenue and Forecast, by Product (2017-2030)

15.2.10.3. Market Revenue and Forecast, by End User (2017-2030)

15.2.10.4. Market Revenue and Forecast, by Component (2017-2030)

15.2.10.5. Market Revenue and Forecast, by Type (2017-2030)

15.2.10.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.2.10.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.2.10.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.2.11.  France

15.2.11.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.2.11.2. Market Revenue and Forecast, by Product (2017-2030)

15.2.11.3. Market Revenue and Forecast, by End User (2017-2030)

15.2.11.4. Market Revenue and Forecast, by Component (2017-2030)

15.2.11.5. Market Revenue and Forecast, by Type (2017-2030)

15.2.11.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.2.11.7. Market Revenue and Forecast, by End-Use (2017-2030)

15.2.11.8. Market Revenue and Forecast, by Lethality (2017-2030)

15.2.12. Rest of Europe

15.2.12.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

15.2.12.3. Market Revenue and Forecast, by End User (2017-2030)

15.2.12.4. Market Revenue and Forecast, by Component (2017-2030)

15.2.12.5. Market Revenue and Forecast, by Type (2017-2030)

15.2.12.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.2.12.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.2.12.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.3. APAC

15.3.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.3.2. Market Revenue and Forecast, by Product (2017-2030)

15.3.3. Market Revenue and Forecast, by End User (2017-2030)

15.3.4. Market Revenue and Forecast, by Component (2017-2030)

15.3.5. Market Revenue and Forecast, by Type (2017-2030)

15.3.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.3.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.3.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.3.9. India

15.3.9.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.3.9.2. Market Revenue and Forecast, by Product (2017-2030)

15.3.9.3. Market Revenue and Forecast, by End User (2017-2030)

15.3.9.4. Market Revenue and Forecast, by Component (2017-2030)

15.3.9.5. Market Revenue and Forecast, by Type (2017-2030)

15.3.9.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.3.9.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.3.9.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.3.10. China

15.3.10.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

15.3.10.3. Market Revenue and Forecast, by End User (2017-2030)

15.3.10.4. Market Revenue and Forecast, by Component (2017-2030)

15.3.10.5. Market Revenue and Forecast, by Type (2017-2030)

15.3.10.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.3.10.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.3.10.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.3.11. Japan

15.3.11.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

15.3.11.3. Market Revenue and Forecast, by End User (2017-2030)

15.3.11.4. Market Revenue and Forecast, by Component (2017-2030)

15.3.11.5. Market Revenue and Forecast, by Type (2017-2030)

15.3.11.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.3.11.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.3.11.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.3.12. Rest of APAC

15.3.12.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.3.12.2. Market Revenue and Forecast, by Product (2017-2030)

15.3.12.3. Market Revenue and Forecast, by End User (2017-2030)

15.3.12.4. Market Revenue and Forecast, by Component (2017-2030)

15.3.12.5. Market Revenue and Forecast, by Type (2017-2030)

15.3.12.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.3.12.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.3.12.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.4. MEA

15.4.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.4.2. Market Revenue and Forecast, by Product (2017-2030)

15.4.3. Market Revenue and Forecast, by End User (2017-2030)

15.4.4. Market Revenue and Forecast, by Component (2017-2030)

15.4.5. Market Revenue and Forecast, by Type (2017-2030)

15.4.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.4.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.4.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.4.9. GCC

15.4.9.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.4.9.2. Market Revenue and Forecast, by Product (2017-2030)

15.4.9.3. Market Revenue and Forecast, by End User (2017-2030)

15.4.9.4. Market Revenue and Forecast, by Component (2017-2030)

15.4.9.5. Market Revenue and Forecast, by Type (2017-2030)

15.4.9.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.4.9.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.4.9.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.4.10. North Africa

15.4.10.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

15.4.10.3. Market Revenue and Forecast, by End User (2017-2030)

15.4.10.4. Market Revenue and Forecast, by Component (2017-2030)

15.4.10.5. Market Revenue and Forecast, by Type (2017-2030)

15.4.10.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.4.10.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.4.10.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.4.11. South Africa

15.4.11.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

15.4.11.3. Market Revenue and Forecast, by End User (2017-2030)

15.4.11.4. Market Revenue and Forecast, by Component (2017-2030)

15.4.11.5. Market Revenue and Forecast, by Type (2017-2030)

15.4.11.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.4.11.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.4.11.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.4.12. Rest of MEA

15.4.12.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.4.12.2. Market Revenue and Forecast, by Product (2017-2030)

15.4.12.3. Market Revenue and Forecast, by End User (2017-2030)

15.4.12.4. Market Revenue and Forecast, by Component (2017-2030)

15.4.12.5. Market Revenue and Forecast, by Type (2017-2030)

15.4.12.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.4.12.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.4.12.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.5. Latin America

15.5.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.5.2. Market Revenue and Forecast, by Product (2017-2030)

15.5.3. Market Revenue and Forecast, by End User (2017-2030)

15.5.4. Market Revenue and Forecast, by Component (2017-2030)

15.5.5. Market Revenue and Forecast, by Type (2017-2030)

15.5.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.5.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.5.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.5.9. Brazil

15.5.9.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.5.9.2. Market Revenue and Forecast, by Product (2017-2030)

15.5.9.3. Market Revenue and Forecast, by End User (2017-2030)

15.5.9.4. Market Revenue and Forecast, by Component (2017-2030)

15.5.9.5. Market Revenue and Forecast, by Type (2017-2030)

15.5.9.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.5.9.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.5.9.8. Market Revenue and Forecast, by End-Use (2017-2030)

15.5.10.   Rest of LATAM

15.5.10.1. Market Revenue and Forecast, by Caliber (2017-2030)

15.5.10.2. Market Revenue and Forecast, by Product (2017-2030)

15.5.10.3. Market Revenue and Forecast, by End User (2017-2030)

15.5.10.4. Market Revenue and Forecast, by Component (2017-2030)

15.5.10.5. Market Revenue and Forecast, by Type (2017-2030)

15.5.10.6. Market Revenue and Forecast, by Guidance (2017-2030)

15.5.10.7. Market Revenue and Forecast, by Lethality (2017-2030)

15.5.10.8. Market Revenue and Forecast, by End-Use (2017-2030)

Chapter 16. Company Profiles

16.1. Northrop Grumman Corporation

16.1.1. Company Overview

16.1.2. Product Offerings

16.1.3. Financial Performance

16.1.4. Recent Initiatives

16.2. FN Herstal

16.2.1. Company Overview

16.2.2. Product Offerings

16.2.3. Financial Performance

16.2.4. Recent Initiatives

16.3. Olin Corporation

16.3.1. Company Overview

16.3.2. Product Offerings

16.3.3. Financial Performance

16.3.4. Recent Initiatives

16.4. General Dynamics Corporation

16.4.1. Company Overview

16.4.2. Product Offerings

16.4.3. Financial Performance

16.4.4. Recent Initiatives

16.5. BAE Systems, Inc.

16.5.1. Company Overview

16.5.2. Product Offerings

16.5.3. Financial Performance

16.5.4. Recent Initiatives

16.6. Rheinmetall Defense

16.6.1. Company Overview

16.6.2. Product Offerings

16.6.3. Financial Performance

16.6.4. Recent Initiatives

16.7. Nexter KNDS Group

16.7.1. Company Overview

16.7.2. Product Offerings

16.7.3. Financial Performance

16.7.4. Recent Initiatives

16.8. Hanwha Corporation

16.8.1. Company Overview

16.8.2. Product Offerings

16.8.3. Financial Performance

16.8.4. Recent Initiatives

16.9. ST Engineering

16.9.1. Company Overview

16.9.2. Product Offerings

16.9.3. Financial Performance

16.9.4. Recent Initiatives

16.10. Remington Arms Company LLC

16.10.1. Company Overview

16.10.2. Product Offerings

16.10.3. Financial Performance

16.10.4. Recent Initiatives

Chapter 17. Research Methodology

16.7. Primary Research

16.7. Secondary Research

16.7. Assumptions

Chapter 18. Appendix

18.1. About Us

18.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

Post a Comment

0 Comments